Kraig Biocraft Laboratories (KBLB) Accumulated Expenses (2010 - 2025)

Kraig Biocraft Laboratories (KBLB) has 16 years of Accumulated Expenses data on file, last reported at $3.6 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses rose 15.72% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (up 15.72% YoY), and the FY2025 full-year result was $3.6 million, up 15.72% from the prior year.
• Accumulated Expenses grew to $3.6 million in Q4 2025, from $3.5 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $3.6 million in Q4 2025 to a low of $980.0 in Q2 2024.
• A 5-year average of $1.2 million and a median of $74202.5 in 2021 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses tumbled 94.53% in 2022 and soared 343880.51% in 2025, its largest moves.
• Tracing KBLB's Accumulated Expenses over 5 years: stood at $31657.0 in 2021, then surged by 7091.0% to $2.3 million in 2022, then surged by 54.47% to $3.5 million in 2023, then declined by 11.02% to $3.1 million in 2024, then climbed by 15.72% to $3.6 million in 2025.
• Business Quant data shows KBLB's Accumulated Expenses at $3.6 million in Q4 2025, $3.5 million in Q3 2025, and $3.4 million in Q2 2025.